Proton-Based Chemoradiotherapy-What Level of Evidence Is Necessary to Justify Its Widespread Use?

[1]  J. Metz,et al.  Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. , 2019, JAMA oncology.

[2]  P. Thall,et al.  Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer , 2019, International Journal of Radiation Oncology*Biology*Physics.

[3]  N. Yue,et al.  Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment. , 2019, International journal of radiation oncology, biology, physics.

[4]  A. Garden,et al.  Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. , 2018, Seminars in radiation oncology.

[5]  Radhe Mohan,et al.  Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  L. Wilson,et al.  Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non–Small-Cell Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  Steven E Schild,et al.  Re: Proton vs intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. , 2013, Journal of the National Cancer Institute.

[8]  Cary P Gross,et al.  Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. , 2013, Journal of the National Cancer Institute.